Baclofen Active Pharmaceutical Ingredient from Taizhou Xinyou Pharmaceutical and Chemical: FDA Statement - FDA Warns of Potential Contamination

The affected lots may potentially pose serious safety risks for U.S. patients who use or receive injectable drug products compounded with

the affected baclofen, especially when administered directly into the spinal column.